Novel use of 1-(4-(5-cyanoindol-3- yl)butyl)-4-(2-carbamoyl- benzofuran-5-yl)-piperazine and its physiologically acceptable salts
A Standard patent application filed on 16 May 2000 credited to Bartoszyk, Gerd ; Seyfried, Christoph ; Sedman, Ewen ; Bottcher, Henning Dr. ; Van Amsterdam, Christoph

Details

Application number :

50663  

Application type :

Standard  

Application status :

SEALED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Novel use of 1-(4-(5-cyanoindol-3- yl)butyl)-4-(2-carbamoyl- benzofuran-5-yl)-piperazine and its physiologically acceptable salts  

Inventor :

Bartoszyk, Gerd ; Seyfried, Christoph ; Sedman, Ewen ; Bottcher, Henning Dr. ; Van Amsterdam, Christoph  

Agent name :

Davies Collison Cave  

Address for service :

GPO Box 3876 SYDNEY NSW 2001  

Filing date :

16 May 2000  

Associated companies :

 

Applicant name :

Merck Patent GmbH  

Applicant address :

Frankfurter Strasse 250 D-64293 Darmstadt Germany  

Old name :

 

Original Source :

Go